cefuroxime has been researched along with Intestinal Diseases in 3 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " ISP was administered in combination with one of the second generation cephems among cefotiam (CTM), cefmetazole (CMZ), or cefuroxime (CXM) for 26 cases of wound infection and 7 cases of peritonitis." | 5.08 | [Combination use of second generation cephem and isepamicin for the treatment of post-surgical infection of the lower digestive tract]. ( Abe, M; Imaoka, Y; Kamiyama, Y; Kunii, Y; Masamune, R; Momono, S; Oouchi, K; Toyoda, T; Toyoshima, T; Watanabe, I, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhan, M | 1 |
| Liang, X | 1 |
| Chen, J | 1 |
| Yang, X | 1 |
| Han, Y | 1 |
| Zhao, C | 1 |
| Xiao, J | 1 |
| Cao, Y | 1 |
| Xiao, H | 1 |
| Song, M | 1 |
| Corbett, CR | 1 |
| Hollands, MJ | 1 |
| Young, AE | 1 |
| Masamune, R | 1 |
| Kunii, Y | 1 |
| Watanabe, I | 1 |
| Imaoka, Y | 1 |
| Momono, S | 1 |
| Toyoshima, T | 1 |
| Toyoda, T | 1 |
| Abe, M | 1 |
| Oouchi, K | 1 |
| Kamiyama, Y | 1 |
1 trial available for cefuroxime and Intestinal Diseases
| Article | Year |
|---|---|
[Combination use of second generation cephem and isepamicin for the treatment of post-surgical infection of the lower digestive tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefmetazole; Cefotiam; Cefuroxime; Cephalospo | 1997 |
2 other studies available for cefuroxime and Intestinal Diseases
| Article | Year |
|---|---|
Dietary 5-demethylnobiletin prevents antibiotic-associated dysbiosis of gut microbiota and damage to the colonic barrier.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyric Acid; Cefuroxime; Colon; Dysbiosis; Gastrointestin | 2023 |
Penetration of a prophylactic antibiotic into peritoneal fluid.
Topics: Adolescent; Adult; Aged; Ascitic Fluid; Cefuroxime; Cephalosporins; Emergencies; Humans; Injections, | 1981 |